Seattle-based biotech company, Mozart Therapeutics, has successfully raised an additional $25M in Series A financing, increasing the total funding to $80M. The company plans to channel these resources into the clinical development of their first therapeutic candidate, MTX-101, along with pipeline expansion. New investors in the round include Pfizer Ventures, AbbVie Ventures, Ono Venture Investment, and UPMC Enterprises. This additional financial commitment…
Swedish women’s health company Gedea Biotech has raises €1.3M (14 MSEK) to further develop its pHyph, an innovative antibiotic-free treatment for vaginal infections. Vaginal infections affect over 400 million women annually. The fresh funds will support critical development activities, including ongoing proof-of-concept studies, clinical trials, and exploring the impact of pHyph on the vaginal microbiome. The funding round attracted current and new…
Kallyope is a clinical stage biotechnology company that is leveraging its proprietary Klarity therapeutic platform to discover and develop novel, oral small-molecule therapeutics in areas with high unmet medical need, including diabetes and obesity, gastrointestinal disease, and neurological disorders. Kallyope focuses on the gut-brain axis, a bi-directional communication between the gastrointestinal tract and the brain. Recent research has suggested that this communication…
Earlier this year Celmatix, a New York-based pre-clinical stage biotech company focused on ovarian biology, announced that a second novel PCOS target identified as part of its five-year, multi-target alliance with Evotec, progressed into hit-identification. Building on this success the company is now doubling down on its efforts, and launching a new Polycystic Ovary Syndrome (PCOS) drug program targeting melatonin receptors outside of the central…
Tally Health, a consumer biotechnology company created to change the way we age, has raised $10M in seed funding. Tally Health’s proprietary and science-based tools aim to improve healthspan and extend longevity at the cellular level with TallyAge epigenetic age tests, personalized lifestyle recommendations, and research-backed longevity supplements. Tally Health, which launched late February, was co-founded by Dr. David Sinclair, a leading expert on aging…
Celmatix, a leading biotech company specializing in ovarian biology for women’s health, has released the findings from a long-term research collaboration with the University of Oxford and 24 other institutions to decode the genetic underpinnings of endometriosis. This condition affects approximately 1 in 10 women worldwide (190 million globally) and has enormous implications for the quality of life. The severe inflammatory condition…
Berlin-based startup theblood has raised close to €1M in pre-seed funding to advance research on menstrual blood analysis and biomarkers as well as the development of a non-invasive blood at-home test that helps menstruators monitor their health. The round was led by RoX Health with participation from Leanox VC and several business angels including HealthHero and Fernarzt Founder Felix Kaiser, Prof. Dr.…
According to the Centers for Disease Control and Prevention, around 1 in 8 women experience significant symptoms of perinatal mood and anxiety disorders that can negatively impact their overall health, daily activities, and family life. Cedars-Sinai investigators have now discovered that women who developed mood and anxiety disorders related to pregnancy and childbirth had altered proteins circulating in their bloodstream during the…
